Imran Talat 4
4 · Rani Therapeutics Holdings, Inc. · Filed Mar 22, 2024
Insider Transaction Report
Form 4
Imran Talat
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-21+1,085,000→ 1,085,000 totalExercise: $3.60Exp: 2034-03-20→ Class A Common Stock (1,085,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024.